Randomized Controlled Trial
A research study design in which participants or subjects are randomly assigned to treatment or control conditions to establish causal relationships between compound and outcome.
Definition
A randomized controlled trial (RCT) is a study design in which subjects are randomly allocated to receive either the experimental treatment or a control condition (placebo or active comparator). Randomization distributes known and unknown confounding factors across groups, enabling valid causal inference about the effect of the treatment. RCTs are considered the gold standard for establishing causal efficacy in research because randomization eliminates selection bias. In preclinical animal research, RCT design principles are applied through random cage assignment and blinded outcome assessment. In human clinical research, RCTs require regulatory approval and ethical oversight.
Research Context
Most published research on peptide compounds for the research-grade compounds sold by Spartan Peptides represents preclinical, not human RCT, data. Understanding this distinction is important for accurately interpreting published research. Rodent in vivo experiments can implement randomized, blinded, controlled design principles but do not constitute human clinical evidence. The research-grade compounds available for in vitro research are referenced in the context of preclinical literature, not human RCT outcomes.
Relevant Compounds
This term applies to the following research compound hubs.
Frequently Asked Questions
Explore the Research Library
Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.